8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...

8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval

8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...

8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...

8/14/2025Remegen's Telitacicept Achieves Phase III Success

8/14/2025CTTQ Unveils Promising Phase 2 Data for HER2 Bispecific ADC TQB2102

8/14/2025GenFleet's GFH375 KRAS G12D Inhibitor Delivers Strong NSCLC Data

8/14/2025Qihan Earns FDA Green Light for Pioneering Dual-Target CAR-T Therapy i...

8/14/2025Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of Oral GLP-1 Ago...

8/14/2025ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by W...

8/13/2025Gracell Gains NMPA Approval to Advance GC012F into Light-Chain Amyloid...

8/13/2025CTTQ Secures IND Acceptance from China's NMPA for Two Innovative Cance...

8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China

8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...

8/8/2025AstraZeneca Expands Use of Fasenra in China

8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...

8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...

8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...

8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery

8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial

8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...

8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD

8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...

8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...

8/4/2025Novartis Submits Zolgensma for Approval in China with Priority Review ...

8/4/2025Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...

8/4/2025China Grants First-Time Approval to Eight New Drugs in July 2025

Page:1/18 Total number of articles:534: [First][<<] [1] [2] [3] [4] [5] [>>] [End]